# Characterizing Skin Microbiome Change in Atopic Dermatitis

> **NCT04800185** · EARLY_PHASE1 · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 20 (actual)

## Conditions studied

- Atopic Dermatitis
- Atopic Dermatitis Eczema

## Interventions

- **DRUG:** Crisaborole 2% Top Oint
- **GENETIC:** Skin Microbiome Swabs

## Key facts

- **NCT ID:** NCT04800185
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-23
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04800185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04800185, "Characterizing Skin Microbiome Change in Atopic Dermatitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04800185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*